東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Targets and emerging therapies for s...

Albert, Jeffrey S.

Linked to FindBook

Google Book

Amazon

博客來

Targets and emerging therapies for schizophrenia

Record Type:	Electronic resources : Monograph/item
Title/Author:	Targets and emerging therapies for schizophrenia/ edited by Jeffrey S. Albert, Michael W. Wood.
other author:	Albert, Jeffrey S.
Published:	Hoboken, New Jersey :John Wiley & Sons, : c2012.,
Description:	1 online resource.
[NT 15003449]:	Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- À7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihály Hajós, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard.
Subject:	Schizophrenia - Treatment. -
Online resource:	http://onlinelibrary.wiley.com/book/10.1002/9781118309421
ISBN:	9781118309407 ( epub)

Targets and emerging therapies for schizophrenia
Targets and emerging therapies for schizophrenia[electronic resource] /edited by Jeffrey S. Albert, Michael W. Wood. - Hoboken, New Jersey :John Wiley & Sons,c2012. - 1 online resource.

Includes bibliographical references and index.

Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- À7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihály Hajós, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard.

ISBN: 9781118309407 ( epub)

LCCN: 2011052987Subjects--Topical Terms:

535564
Schizophrenia
--Treatment.

LC Class. No.: RC514

Dewey Class. No.: 616.89/8061

National Library of Medicine Call No.: WM 203

Targets and emerging therapies for schizophrenia
LDR:03395cmm a2200409 a 4500 001 2003195
003 OCoLC
005 20151013060209.0
006 m o d
007 cr |||||||||||
008 151223s2012 nju sb 001 0 eng
010 $a 2011052987
020 $a 9781118309407 ( epub)
020 $a 1118309405 ( epub)
020 $a 9781118309384 (epdf)
020 $a 1118309383 (epdf)
020 $a 9781118309391 (emobi)
020 $a 1118309391 (emobi)
020 $z 9780470322826 (cloth)
020 $a 9781118309421 (electronic bk.)
020 $a 1118309421 (electronic bk.)
020 $a 1280699310
020 $a 9781280699313
020 $a 0470322829 (cloth)
020 $a 9780470322826 (cloth)
035 $a (OCoLC)769289644 $z (OCoLC)795894798 $z (OCoLC)798698963 $z (OCoLC)808669946 $z (OCoLC)817089457
035 $a ocn769289644
040 $a DLC $b eng $c DLC $d EBLCP $d IDEBK $d N $d DG1 $d YDXCP $d E7B $d STF $d COO $d UBY $d NLGGC $d OCLCF
050 0 0 $a RC514
060 1 0 $a WM 203
082 0 0 $a 616.89/8061 $2 23
245 0 0 $a Targets and emerging therapies for schizophrenia $h [electronic resource] / $c edited by Jeffrey S. Albert, Michael W. Wood.
260 $a Hoboken, New Jersey : $b John Wiley & Sons, $c c2012.
300 $a 1 online resource.
504 $a Includes bibliographical references and index.
505 0 $a Dopaminergic hypothesis of schizophrenia : a historical perspective / Aurelija Jucaite and Svante Nyberg -- Dopamine D2/D3 partial agonists as antipsychotics / Philip G. Strange -- D1/D5 dopamine agonists as pharmacotherapy for schizophrenia / Kevin N. Boyd and Richard B. Mailman -- PDE inhibitors as a novel therapeutic approach for schizophrenia / Judith A. Siuciak and William J. Pitts -- Glutamatergic synaptic dysregulation in schizophrenia / Joseph T. Coyle, Alo Basu, and Michael Benneyworth -- Metabotropic glutamate 2/3 receptor agonists and positive allosteric modulators of metabotropic glutamate receptor 2 as novel agents for the treatment of schizophrenia / Gerard J. Marek ... [et al.] -- AMPA receptor positive modulators / John A. Morrow, John K.F. Maclean, and Craig Jamieson -- Progress in the exploration and development of GlyT1 inhibitors for schizophrenia / Jeffrey S. Albert and Michael W. Wood -- Combined dopamine D2 and 5-hydroxytryptamine (5-HT)1a receptor strategies for the treatment of schizophrenia, a pharmacological and chemical perspective / Andrew C. Mccreary, Roelof W. Feenstra, and Caitlin A. Jones -- 5-HT2C and 5-HT6 receptor targeted emerging approaches in schizophrenia / Sharon Rosenzweig-Lipson ... [et al.] -- The cholinergic hypothesis : an introduction to the hypothesis and a short history / Joseph I. Friedman, Isabella Kanellopoulou, and Vladan Novakovic -- À7 nicotinic acetylcholine receptors in the treatment of schizophrenia / Mihály Hajós, and Bruce N. Rogers -- Muscarinic acetylcholine receptors as novel targets for the development of therapeutics for schizophrenia / Christian C. Felder ... [et al.] -- Will modulation of neuropeptide receptors produce the next generation of antipsychotic drugs? : a focus on the neurokinin and neurotensin systems / Lee A. Dawson, Paul W. Smith, and Jeannette M. Watson -- GABA and schizophrenia / John H. Kehne and George D. Maynard.
588 $a Description based on print version record and CIP data provided by publisher.
650 0 $a Schizophrenia $x Treatment. $3 535564
700 1 $a Albert, Jeffrey S. $3 2148274
700 1 $a Wood, Michael W. $q (Michael William), $d 1961- $3 2148275
856 4 0 $u http://onlinelibrary.wiley.com/book/10.1002/9781118309421